NYSE:TFX Teleflex - TFX Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Teleflex Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. $241.34 +0.54 (+0.22%) (As of 03/23/2023 12:00 AM ET) Add Compare Share Share Today's Range$240.62▼$245.7850-Day Range$222.88▼$262.2252-Week Range$182.65▼$356.72Volume343,013 shsAverage Volume354,718 shsMarket Capitalization$11.33 billionP/E Ratio31.42Dividend Yield0.56%Price Target$271.69 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Teleflex MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside12.6% Upside$271.69 Price TargetShort InterestHealthy2.26% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-1.53Upright™ Environmental ScoreNews Sentiment0.50Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth10.01%From $13.29 to $14.62 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.69 out of 5 starsMedical Sector65th out of 986 stocksSurgical & Medical Instruments Industry7th out of 100 stocks 3.3 Analyst's Opinion Consensus RatingTeleflex has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $271.69, Teleflex has a forecasted upside of 12.6% from its current price of $241.34.Amount of Analyst CoverageTeleflex has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.26% of the outstanding shares of Teleflex have been sold short.Short Interest Ratio / Days to CoverTeleflex has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Previous Next 1.7 Dividend Strength Dividend YieldTeleflex has a dividend yield of 0.57%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthTeleflex does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Teleflex is 17.71%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Teleflex will have a dividend payout ratio of 9.30% next year. This indicates that Teleflex will be able to sustain or increase its dividend. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTeleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for Teleflex is -1.53. Previous Next 1.9 News and Social Media Coverage News SentimentTeleflex has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Teleflex this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for TFX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Teleflex insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.28% of the stock of Teleflex is held by insiders.Percentage Held by Institutions93.82% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Teleflex are expected to grow by 10.01% in the coming year, from $13.29 to $14.62 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Teleflex is 31.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Teleflex is 31.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 113.56.Price to Earnings Growth RatioTeleflex has a PEG Ratio of 2.49. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioTeleflex has a P/B Ratio of 2.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Teleflex (NYSE:TFX) StockTeleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.Read More Receive TFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter. Email Address TFX Stock News HeadlinesMarch 19, 2023 | americanbankingnews.comAnalysts Set Teleflex Incorporated (NYSE:TFX) PT at $271.69March 17, 2023 | americanbankingnews.comTeleflex (NYSE:TFX) Upgraded by StockNews.com to "Buy"March 23, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...March 13, 2023 | seekingalpha.comTeleflex highlights benefits of UroLift System for enlarged prostateMarch 10, 2023 | finance.yahoo.comIs It Time To Consider Buying Teleflex Incorporated (NYSE:TFX)?March 7, 2023 | finance.yahoo.comTeleflex to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum: VirtualFebruary 26, 2023 | finance.yahoo.comTeleflex Incorporated (NYSE:TFX) Q4 2022 Earnings Call TranscriptFebruary 24, 2023 | finance.yahoo.comTeleflex (TFX) Q4 Earnings Top Estimates, Operating Margin DownMarch 23, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. February 24, 2023 | finance.yahoo.comTeleflex Full Year 2022 Earnings: EPS Misses ExpectationsFebruary 23, 2023 | finance.yahoo.comTeleflex (TFX) Surpasses Q4 Earnings EstimatesFebruary 22, 2023 | finance.yahoo.comTeleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)February 21, 2023 | finance.yahoo.comTeleflex to Present at the 44th Annual Raymond James Institutional Investors ConferenceFebruary 9, 2023 | finance.yahoo.comTeleflex Announces Fourth Quarter 2022 Earnings Conference Call InformationFebruary 9, 2023 | finance.yahoo.comTeleflex Incorporated's (NYSE:TFX) Stock Is Going Strong: Is the Market Following Fundamentals?February 7, 2023 | finance.yahoo.comStandard Bariatrics, Inc., now part of Teleflex, Awarded Bariatric Stapling Technology Agreement with Premier Inc.February 6, 2023 | finance.yahoo.comTeleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged ProstateFebruary 1, 2023 | finance.yahoo.comWill Teleflex (TFX) Beat Estimates Again in Its Next Earnings Report?January 26, 2023 | finance.yahoo.comThe Zacks Analyst Blog Highlights Comcast, Aon, Trane Technologies, Huntington Bancshares and TeleflexJanuary 25, 2023 | marketwatch.comTeleflex Inc. stock falls Tuesday, underperforms marketJanuary 25, 2023 | marketwatch.comTeleflex Inc. stock outperforms market on strong trading dayJanuary 17, 2023 | finance.yahoo.comReturn Trends At Teleflex (NYSE:TFX) Aren't AppealingDecember 29, 2022 | finance.yahoo.comMedical device maker Teleflex to shutter Pleasanton, Livermore facilitiesDecember 28, 2022 | finance.yahoo.comTeleflex (NYSE:TFX) shareholders have endured a 33% loss from investing in the stock three years agoDecember 27, 2022 | finance.yahoo.comTeleflex to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 15, 2022 | finance.yahoo.comTeleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® SystemNovember 30, 2022 | finance.yahoo.comIs Teleflex Incorporated (NYSE:TFX) Trading At A 37% Discount?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter. Email Address TFX Company Calendar Last Earnings2/23/2023Ex-Dividend for 3/15 Dividend3/02/2023Dividend Payable3/15/2023Today3/23/2023Next Earnings (Estimated)4/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:TFX CUSIP87936910 CIK96943 Webwww.teleflex.com Phone(610) 225-6800Fax215-553-5402Employees15,500Year Founded1943Price Target and Rating Average Stock Price Forecast$271.69 High Stock Price Forecast$330.00 Low Stock Price Forecast$210.00 Forecasted Upside/Downside+12.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$7.68 Trailing P/E Ratio31.42 Forward P/E Ratio18.16 P/E Growth2.49Net Income$363.14 million Net Margins13.01% Pretax Margin15.98% Return on Equity15.87% Return on Assets9.05% Debt Debt-to-Equity Ratio0.40 Current Ratio2.43 Quick Ratio1.43 Sales & Book Value Annual Sales$2.79 billion Price / Sales4.06 Cash Flow$18.48 per share Price / Cash Flow13.06 Book Value$85.74 per share Price / Book2.81Miscellaneous Outstanding Shares46,940,000Free Float46,343,000Market Cap$11.33 billion OptionableOptionable Beta0.98 Social Links Key ExecutivesLiam J. KellyChairman, President & Chief Executive OfficerThomas E. PowellChief Financial Officer & Executive Vice PresidentJustin McMurrayVP-Global Strategic Research & DevelopmentTimothy F. DuffyChief Information Officer & Vice PresidentMichelle FoxChief Medical Officer & Vice PresidentKey CompetitorsGlobus MedicalNYSE:GMEDIntegra LifeSciencesNASDAQ:IARTBaxter InternationalNYSE:BAXInsuletNASDAQ:PODDResMedNYSE:RMDView All CompetitorsInsiders & InstitutionsMetLife Investment Management LLCSold 200 shares on 3/23/2023Ownership: 0.026%ETF Managers Group LLCBought 75 shares on 3/23/2023Ownership: 0.004%Mather Group LLC.Bought 882 shares on 3/10/2023Ownership: 0.002%Rockefeller Capital Management L.P.Bought 622 shares on 3/6/2023Ownership: 0.005%Voya Investment Management LLCBought 472 shares on 2/28/2023Ownership: 0.035%View All Insider TransactionsView All Institutional Transactions TFX Stock - Frequently Asked Questions Should I buy or sell Teleflex stock right now? 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TFX shares. View TFX analyst ratings or view top-rated stocks. What is Teleflex's stock price forecast for 2023? 12 Wall Street research analysts have issued twelve-month price targets for Teleflex's shares. Their TFX share price forecasts range from $210.00 to $330.00. On average, they expect the company's share price to reach $271.69 in the next twelve months. This suggests a possible upside of 12.6% from the stock's current price. View analysts price targets for TFX or view top-rated stocks among Wall Street analysts. How have TFX shares performed in 2023? Teleflex's stock was trading at $249.63 on January 1st, 2023. Since then, TFX shares have decreased by 3.3% and is now trading at $241.34. View the best growth stocks for 2023 here. When is Teleflex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023. View our TFX earnings forecast. How were Teleflex's earnings last quarter? Teleflex Incorporated (NYSE:TFX) posted its quarterly earnings results on Thursday, February, 23rd. The medical technology company reported $3.52 earnings per share for the quarter, beating analysts' consensus estimates of $3.44 by $0.08. The medical technology company earned $758 million during the quarter, compared to the consensus estimate of $760.29 million. Teleflex had a trailing twelve-month return on equity of 15.87% and a net margin of 13.01%. The business's revenue for the quarter was down .5% on a year-over-year basis. During the same period last year, the company earned $3.60 earnings per share. Read the conference call transcript. How often does Teleflex pay dividends? What is the dividend yield for Teleflex? Teleflex announced a quarterly dividend on Thursday, February 23rd. Stockholders of record on Friday, March 3rd will be paid a dividend of $0.34 per share on Wednesday, March 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Thursday, March 2nd. Read our dividend analysis for TFX. What ETFs hold Teleflex's stock? ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P 500 Equal Weight Health Care ETF (RYH), SPDR S&P Health Care Equipment ETF (XHE), iShares U.S. Medical Devices ETF (IHI), Principal Quality ETF (PSET), First Trust Mid Cap US Equity Select ETF (RNMC), Global X Aging Population ETF (AGNG) and First Trust Health Care AlphaDEX Fund (FXH). Is Teleflex a good dividend stock? Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 17.71%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.30% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for TFX. What guidance has Teleflex issued on next quarter's earnings? Teleflex updated its FY23 earnings guidance on Thursday, February, 23rd. The company provided EPS guidance of $13.00-13.60 for the period, compared to the consensus estimate of $13.49. The company issued revenue guidance of ~$2.91-2.95 billion, compared to the consensus revenue estimate of $2.92 billion. What is Liam Kelly's approval rating as Teleflex's CEO? 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees. What other stocks do shareholders of Teleflex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO). What is Teleflex's stock symbol? Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX." Who are Teleflex's major shareholders? Teleflex's stock is owned by a number of retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (18.40%), Morgan Stanley (5.74%), Price T Rowe Associates Inc. MD (2.60%), Geode Capital Management LLC (2.02%), Allspring Global Investments Holdings LLC (1.71%) and Bessemer Group Inc. (1.13%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle. View institutional ownership trends. How do I buy shares of Teleflex? Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Teleflex's stock price today? One share of TFX stock can currently be purchased for approximately $241.34. How much money does Teleflex make? Teleflex (NYSE:TFX) has a market capitalization of $11.33 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.68 on an earnings per share basis. How many employees does Teleflex have? The company employs 15,500 workers across the globe. How can I contact Teleflex? Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402. This page (NYSE:TFX) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.